Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence.
He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.
Suicide rates in the United States have seen an alarming rise in recent years, highlighting the urgent need for a...
With the 2024 election approaching, it is crucial to understand the changing dynamics and the implications for patient autonomy.
It feels like vaccines are everywhere. Every news cycle seems to introduce a new vaccine or vaccine formulary. But how...
A little known condition explains Black Friday behavior, notorious for its shopping frenzy, with shoppers displaying aggressive behavior.
A comprehensive guide for diabetic and hypertensive patients to navigate food choices and diet through the holidays.
To support those who might not be aware of their anxieties, we shed light on ten less recognized symptoms and...
We provide guidance on navigating travel during this holiday season, emphasizing the importance of staying informed and vigilant.
We explore how physicians can lose the trust of their patients through the dissemination of misinformation and disinformation.
The holiday season is a time of joy, celebration, and togetherness. However, for those committed to sobriety, it can also...
We aim to shed light on the factors that contribute to the loss of credibility in patients and how these...
We explore the various reasons why patients may lose credibility in the eyes of their healthcare providers, in hopes of...
We summarize the science behind establishing trust and offer practical tips for aspiring authors who seek to write credible health...
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy